Current studies have shown that ALDOA is abnormally expressed in many cancers, such as Lung adenocarcinoma and colorectal cancer8,9, and that ALDOA expression is significantly increased in the serum of some tumour patients, suggesting that ALDOA may be a key molecule in tumour development and malignancy. Here, ALDOA is linked to lung adenocarcinoma.